Evidence map›Paper›PMID 30291812›Full record

ArticleCancer2018

Changes in cardiovascular disease risk and risk factors among women with and without breast cancer.

Chelsea Anderson, Hazel B Nichols, Allison M Deal, Yong-Moon Mark Park, Dale P Sandler

Abstract readComparative Study
In one paragraph

Article in Cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Cancer history as a predictor in cardiovascular risk scores: a primary care cohort study.The British journal of general practice : the journal of the Royal College of General Practitioners · 2023
    Article
  5. Review
  6. Article
  7. Article
  8. Cardiovascular Disease among Breast Cancer Survivors.Cardiovascular disorder and medicine · 2020
    Article
  9. Cardio-toxicity of checkpoint inhibitors.Journal of thoracic disease · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chelsea AndersonDepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.ORCID 0000-0001-6535-481X
Hazel B NicholsDepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.ORCID 0000-0003-0972-1560
Allison M DealBiostatistics and Clinical Data Management Core, University of North Carolina Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Yong-Moon Mark ParkEpidemiology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina.ORCID 0000-0002-5879-6879
Dale P SandlerEpidemiology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina.

Funding

Cancer Control Education ProgramT32CA057726 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Melissa B Gilkey, Melissa A. Troester · 2017 to 2026
$3.7M
Genetic and Environmental Risk Factors for Breast Cancer: The Sister StudyZ01ES044005 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI SANDLER, DALE P · 1999 to 2008
$1.3M
Intramural NIH HHS Z01 ES044005NCI NIH HHS T32 CA057726NIEHS NIH HHS Z01-ES044005NIH HHSUniversity of North Carolina
6 · The paper itself

Abstract

backgroundCardiovascular disease (CVD) risk is an important health concern among survivors of breast cancer. However, few studies to date have examined whether trajectories of CVD risk and major risk factors are worse among women with a breast cancer diagnosis compared with those without.

methodsChanges in weight, body mass index, waist circumference, systolic blood pressure, and 10-year CVD risk were compared between women with (813 women) and without (1049 women) an incident breast cancer diagnosis while they were enrolled in the National Institute of Environmental Health Sciences Sister Study cohort. Blood pressure and adiposity measures were collected by trained examiners at an enrollment visit (≥1 year before breast cancer diagnosis) and a second home visit 4 to 11 years later (≥1 year after breast cancer diagnosis). The non-laboratory-based Framingham risk score, a measure of 10-year general CVD risk, was calculated at both the enrollment and second visits. All analyses were stratified by menopausal status at the time of enrollment.

resultsWomen who were premenopausal at the time of enrollment experienced moderate increases in weight, waist circumference, systolic blood pressure, and CVD risk over the study period. Those who were postmenopausal at the time of enrollment demonstrated little change in weight, but were found to have increases in waist circumference, systolic blood pressure, and CVD risk. In both groups, changes over time did not differ significantly according to breast cancer status. Neither chemotherapy nor endocrine therapy were found to be associated with greater increases in CVD risk or risk factors.

conclusionsIn the current study cohort, changes over time in CVD risk, adiposity measures, and blood pressure were similar between women who developed an incident breast cancer and those who did not.

Indexed as

AdultAgedBlood PressureBody Mass IndexBody WeightBreast NeoplasmsCardiovascular DiseasesCohort StudiesFemaleHumansMiddle AgedPostmenopausePremenopauseProspective StudiesRisk AssessmentRisk Factorsblood pressurebody mass indexbreast cancercardiovascular diseasewaist circumference.

Identifiers

PMID30291812
PMCPMC6289690

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.